Bimega Soft Capsule 300mg (Eicosapentanoic Acid Ethyl)

Adult dose

1. Improvement of ulcers, pain, and coldness caused by obliterative arteriosclerosis Adults: Administer ethyl icosapentate 600mg (2 capsules) orally 3 times daily immediately after meals. 2. Hyperlipidemia Administer ethyl icosapentate 900mg (3 capsules) orally twice daily or 600mg (2 capsules) orally 3 times daily immediately after meals. If an abnormal triglyceride level occurs, the dose may be increased, if needed, to 900mg (3 capsules) 3 times daily.

This medication contains eicosapentanoic acid ethyl, and it is safe not to use in certain patients. Individuals with hypersensitivity to this medication or those with bleeding tendencies may face difficulties in hemostasis if taking this medication and should not receive it. Patients who are menstruating or have bleeding tendencies, scheduled for surgery, have suffered severe trauma, have liver dysfunction, have fish allergies, and those currently taking anticoagulants or antiplatelet drugs should use this medication with caution. This medication may cause serious side effects such as liver dysfunction or jaundice; thus, regular observation of liver condition is necessary, and if abnormalities are detected, it should be discontinued immediately. Additionally, there is a risk of arrhythmias such as atrial fibrillation or atrial flutter, so caution is especially needed in those with a history of heart disease. Various side effects such as skin rash, itching, bleeding, gastrointestinal discomfort, headaches, dizziness, muscle pain, etc., may occur; thus, it is important to consult healthcare professionals if symptoms appear. When used for the treatment of hyperlipidemia, blood lipid levels should be regularly monitored alongside dietary or exercise therapies, and if there is no effect, administration should be discontinued. Patients whose blood pressure is uncontrolled and are taking other antiplatelet agents should be cautious of the risk of hemorrhagic stroke. This medication has antiplatelet effects, and the risk of bleeding may increase if taken together with anticoagulants or antiplatelet drugs. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of this medication, and breastfeeding should be avoided if possible. Safety in children has not been established, and there is no usage experience. It is advised to avoid taking this medication on an empty stomach and to swallow it whole after meals, without chewing it. When storing, keep it out of reach of children and store in a cool, dry place, and it is safe not to transfer it to another container after opening.

• Liver dysfunction
• jaundice
• atrial fibrillation
• atrial flutter
• hypersensitivity
• rash
• itching
• tendency to bleed
• subcutaneous hemorrhage
• hematuria

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is best to maintain storage temperatures between 1 to 30 degrees Celsius at room temperature.

Appearance

Colorless and transparent oval soft capsule containing a colorless or pale yellow transparent liquid.

Package unit

60 capsules/box [(10 capsules/PTP) × 6]